Active, Not Recruiting
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
NCT03513562
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States